119th Congress · introduced in the House · Jul 16, 2025
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
Official title from Congress.gov
Latest action (Jul 16, 2025): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
16 citations.
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: ARENTFOX SCHIFF LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Budget/Appropriations
$50,000
Paid to lobbying firm
…7), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loa…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE COOK GROUP INC. · lobbying firm or registrant: THE COOK GROUP INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$120,000
Spent on own lobbying
…(H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electr…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: INFECTIOUS DISEASES SOCIETY OF AMERICA
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 7, 2026 · issue area: Medical/Disease Research/Clinical Labs
$290,000
Spent on own lobbying
…ation Executive Orders regarding HHS, NIH, HRSA, FDA, and CDC, Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act (119th Congress, H.R. 4445/S.4283), SUPERBUGS Act, H.R.7879, 119th Congress.
Congress stated in the filing; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: INFECTIOUS DISEASES SOCIETY OF AMERICA
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 7, 2026 · issue area: Health Issues
$290,000
Spent on own lobbying
…Physician Fee Schedule, avian flu outbreak (generally, no specific bill), Administration executive orders regarding HHS, NIH, CDC, HRSA, FDA, and USAID FY2026, H.R. 4445/S.4283 Bio-Preparedness Workforce Pilot Program/Public Health Loan Repayment reauthorization legislation, J-1 Visa and Conrad 30 issues, H-1B Visa issues, 2026…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: ARENTFOX SCHIFF LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Budget/Appropriations
$50,000
Paid to lobbying firm
…7), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loa…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE COOK GROUP INC. · lobbying firm or registrant: THE COOK GROUP INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 13, 2026 · issue area: Health Issues
$120,000
Spent on own lobbying
…(H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electr…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: INFECTIOUS DISEASES SOCIETY OF AMERICA
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 22, 2026 · issue area: Health Issues
$169,000
Spent on own lobbying
…Physician Fee Schedule, avian flu outbreak (generally, no specific bill), Administration executive orders regarding HHS, NIH, CDC, HRSA, FDA, and USAID FY2026, H.R. 4445 Bio-Preparedness Workforce Pilot Program/Public Health Loan Repayment reauthorization legislation, J-1 Visa and Conrad 30 issues, H-1B Visa issues, reintroduct…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: INFECTIOUS DISEASES SOCIETY OF AMERICA
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 22, 2026 · issue area: Medical/Disease Research/Clinical Labs
$169,000
Spent on own lobbying
…ation Executive Orders regarding HHS, NIH, HRSA, FDA, and CDC, Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act (119th Congress, H.R. 4445)not yet introduced in Senate, SUPERBUGS Act, H.R.7879, 119th Congress.
Congress stated in the filing; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE COOK GROUP INC. · lobbying firm or registrant: THE COOK GROUP INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 17, 2026 · issue area: Health Issues
$200,000
Spent on own lobbying
…(H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electr…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: ARENTFOX SCHIFF LLP
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 17, 2026 · issue area: Budget/Appropriations
$50,000
Paid to lobbying firm
…6), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill H.R.7148 (Consolidated Appropriations Act, 2026), Divisi…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: INFECTIOUS DISEASES SOCIETY OF AMERICA
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Feb 17, 2026 · issue area: Health Issues
$68,000
Spent on own lobbying
…to End Upsurging Resistance Act (PASTEUR), Infectious diseases and bio-preparedness health professionals loan repayment issues, BIO Preparedness Workforce Act (H.R. 4445), Monkeypox outbreak and response (generally, no specific information), ID incentive payments (no specific information or bill numbers), CMS Medicare Physician…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: ARENTFOX SCHIFF LLP
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 19, 2026 · issue area: Budget/Appropriations
$50,000
Paid to lobbying firm
…h antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSN. OF STATE AND TERRITORIAL HEALTH OFFICIALS · lobbying firm or registrant: ASSN. OF STATE AND TERRITORIAL HEALTH OFFICIALS
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 24, 2025 · issue area: Health Issues
$46,531
Spent on own lobbying
…025 S. 2532 - Safe Response Act S. 2540 - Comprehensive Addiction and Recovery Justice Grant Reauthorization Act of 2025 S. 1941 - Cure Hepatitis C Act of 2025 H.R. 4445 - Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: ARENTFOX SCHIFF LLP
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 17, 2025 · issue area: Budget/Appropriations
$50,000
Paid to lobbying firm
…h antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: INFECTIOUS DISEASES SOCIETY OF AMERICA
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 14, 2025 · issue area: Health Issues
$300,000
Spent on own lobbying
…to End Upsurging Resistance Act (PASTEUR), Infectious diseases and bio-preparedness health professionals loan repayment issues, BIO Preparedness Workforce Act (H.R. 4445), Monkeypox outbreak and response (generally, no specific information), ID incentive payments (no specific information or bill numbers), CMS Medicare Physician…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INFECTIOUS DISEASES SOCIETY OF AMERICA · lobbying firm or registrant: INFECTIOUS DISEASES SOCIETY OF AMERICA
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Aug 13, 2025 · issue area: Health Issues
$285,000
Spent on own lobbying
…Physician Fee Schedule, avian flu outbreak (generally, no specific bill), Administration executive orders regarding HHS, NIH, CDC, HRSA, FDA, and USAID FY2026, H.R. 4445 Bio-Preparedness Workforce Pilot Program/Public Health Loan Repayment reauthorization legislation
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing